FM-AD: Adult Cancer Clinical and Genomic Data for 18,000 Patients

Approximately 18,000 adult patients with diverse cancers are represented in this clinical and biospecimen dataset. Genomic profiling was conducted by Foundation Medicine Inc. using their FoundationOne assay. The dataset is managed by the Center for Translational Data Science at The University of Chicago.

Use Cases

• Identify genomic biomarkers associated with specific cancer types based on the comprehensive profiling assay.
• Correlate clinical outcomes with genomic profiles for adult cancer patients.
• Train predictive models for cancer classification or treatment response using combined clinical and genomic data.

Strengths

• Data from approximately 18,000 patients provides a substantial sample size for analysis.
• Includes a diverse array of cancer types, which may improve model generalizability.
• Combines clinical and biospecimen data, enabling multi-modal analysis.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.
• Last update date is unknown; freshness unverified.

Provenance

Source

Foundation Medicine Inc. (FMI), managed by the Center for Translational Data Science at The University of Chicago.

Collection Method

Genomic profiling data generated using the commercial FoundationOne assay.

Time Range

null

Freshness

Last updated date is unknown.

Geography

null